NDCFind

Hyrimoz 61314-0454-68

Generic: Adalimumab-Adaz

Package NDC

61314-0454-68

Product NDC: 61314-0454

Manufacturer
Sandoz Inc
Dosage Form
Injection, Solution
Route
Subcutaneous
Product Type
Human Prescription Drug
Marketing Start
July 1, 2023
Listing Expires
December 31, 2027
Application
BLA761071
StockMeds — pharmacy-to-pharmacy marketplace

Need to source Hyrimoz? P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

IngredientStrength
Adalimumab80 mg/.8mL

Drug Class

Tumor Necrosis Factor Blocker [EPC]AntibodiesMonoclonal [CS]

Selected Package

61314-0454-68Selected

3 SYRINGE, GLASS in 1 CARTON (61314-454-68) / .8 mL in 1 SYRINGE, GLASS

Other packages for this product(2)

2 SYRINGE in 1 CARTON (61314-454-20) / .8 mL in 1 SYRINGE

3 SYRINGE in 1 CARTON (61314-454-36) / .8 mL in 1 SYRINGE